
Share
A new S-1 filing shows Anthropic's co-founders have structured identical, modest share sales ahead of a potential $1.4 trillion listing, a move that balances personal liquidity against the optics and mechanics of retaining voting control.
Anthropic's IPO filing contains a detail that tells investors as much about governance discipline as it does about personal wealth. Each of the company's seven co-founders plans to sell exactly 3,378,378 shares, no more, no less. At the midpoint of the company's $70 to $78 price range, that works out to roughly $250 million per founder. At the low end, each pockets just over $236 million; at the high end, just under $264 million.
The uniformity is the story here. This isn't a case of a CEO cashing out disproportionately while co-founders hold steady. Dario Amodei, Daniela Amodei, Tom Brown, Jack Clark, Jared Kaplan, Sam McCandlish, and Christopher Olah are all selling the identical share count. That kind of parity rarely happens by accident in a cap table with this much value at stake.
Anthropic is attempting something unusual for a company racing toward a listing that could value it at $1.404 trillion on a fully diluted basis at the top of the range. The offering itself totals 825 million Class A shares, expected to raise between $57.75 billion and $64.35 billion. Layer in a separate $26 billion private placement of non-voting Class N stock to AMD, Broadcom, Google, Micron, Microsoft, Nvidia, and TSMC, with Google and Nvidia each putting in $10 billion, and total net proceeds could reach $93.7 billion if underwriters exercise their option.
Against that backdrop, $250 million per founder is a rounding error. Collectively, the seven are taking roughly $1.75 billion off the table, less than 2% of the smallest projected net proceeds figure. That ratio matters for how the market reads founder intent. This isn't a liquidity event dressed up as an IPO. It's a public offering with a modest, pre-negotiated founder payday attached.
The mechanics of control are the more interesting wrinkle. After the sale, each founder will hold about 3.2% of outstanding Class A shares, roughly 22% collectively, a figure that understates their actual influence. Each also receives one share of Class F stock carrying supervoting rights, and together the group controls 51.1% of total votes. No single founder holds meaningfully more sway than another. That's a governance structure built to prevent any one of the seven, including Dario Amodei as CEO, from accumulating outsized personal leverage over the company post-IPO.
It's worth remembering why these seven are in this position at all. They left OpenAI in 2021 over disagreements about AI development philosophy, with siblings Dario and Daniela Amodei leading five former colleagues into a venture explicitly positioned around AI safety. That origin story is now baked into the corporate structure itself: Anthropic is a public benefit corporation, and its Long-Term Benefit Trust will elect a board majority, meaning Class A buyers in the IPO will have limited practical influence over company direction regardless of how much stock they purchase.

Demand signals in the filing are notable. Board member Reed Hastings has indicated interest in buying $300 million of shares through his donor-advised fund, while fellow board member Christopher Liddell wants $3 million. Anthropic has set an unusually wide initial price band, $70 to $78, which itself suggests uncertainty about where demand will settle, though companies in high-demand IPOs frequently price above their stated range once books are built.
The fundamentals supporting that demand are real. Anthropic's run-rate revenue hit $81 billion by the end of October, up roughly $10 billion from the end of September, a growth rate that would be extraordinary for a company of any size, let alone one approaching a trillion-dollar valuation. Shares are expected to begin trading on the Nasdaq around November 19 under the ticker "ANT," with up to 20% of the offering allocated to retail investors, a relatively generous carve-out for an offering of this scale.
Context matters on valuation, too. The $1.404 trillion top-end figure represents a substantial jump from the $965 billion valuation Anthropic reached in its May fundraise. It's also notably below the $2 trillion figure the company was reportedly targeting just a couple of months ago, a gap that likely reflects the broader pullback in AI investing and shakier market conditions that have characterized recent months. Anthropic pushing ahead regardless signals confidence, or at least urgency, from leadership and underwriters including Goldman Sachs and Morgan Stanley.
For prospective Class A shareholders, the governance math deserves close attention before the control structure gets treated as a footnote. Buying into this IPO means acquiring economic exposure without meaningful voting power. The founders' 51.1% voting control, paired with the Long-Term Benefit Trust's board-majority authority, means public shareholders are underwriting growth and risk while ceding strategic decision-making almost entirely to insiders and the trust structure.
The revenue trajectory is the strongest bull case: $81 billion run-rate and climbing fast is a figure few companies in any sector can match. But the valuation compression from the rumored $2 trillion target to $1.404 trillion at the top of the range suggests the market, or at least underwriters, found a ceiling on enthusiasm. Watch where the stock actually prices relative to that $70 to $78 band, and watch early trading volatility once the 20% retail allocation hits the market on November 19. The founder cash-out itself, at roughly $1.75 billion combined, is immaterial to the deal's success or failure. The real test is whether a public benefit corporation with locked-in founder control and a trust-dominated board can sustain investor enthusiasm once the IPO glow fades.
Tags
Original Sources
All 7 Anthropic founders will each cash out about $250M in IPO | TechCrunch
↗ https://techcrunch.com/2026/11/10/all-7-anthropic-founders-will-each-cash-out-about-250m-in-ipo
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
11 November 2026
14 articles
Related Articles
Related Articles
More Stories
© 2026 Cedar & Bloom. All rights reserved.